Latin America Consortium Industry Committee

Author(s)

Arturo Figueroa, MSc, Pharmamanagement EAS S de RL de CV, Mexico City, DF, Mexico, Patricia Herrera, Eng, MSD Mexico, Mexico, EM, Mexico, Diego F Guarin, MD, MPH, MA, Merck, Kenilworth, NJ, USA and Marcos Santos, MD, PhD, UNESCO Chair of Bioethics - Brasilia University, Sao Paulo, SP, Brazil

The Role of Industry in Generating and Utilizing RWE for Decision-Making

During this meeting, we will explore the important role that industry plays in generating and utilizing Real-World Evidence (RWE) to inform decision-making processes. As healthcare systems increasingly rely on data-driven insights, the importance of RWE in shaping policy, clinical guidelines, and regulatory approvals has grown exponentially. Industry stakeholders are at the forefront of this movement, leveraging RWE to demonstrate the value and effectiveness of their products in real-world settings.

Various aspects of RWE, including data collection methods, analytical techniques, and the integration of RWE into regulatory and reimbursement frameworks in Latin America. Participants will gain insights into best practices for collaborating with healthcare providers, payers, and policymakers to ensure that RWE is utilized effectively and ethically. By sharing case studies and discussing emerging trends, this forum aims to highlight the transformative impact of RWE on healthcare decision-making and the collaborative efforts needed to advance this field in Latin America.

Join us to understand how the industry can contribute to generating high-quality RWE and support evidence-based policy decisions.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×